Fields »
ABOUT
HELP
BLOG

227 GENES FOUND

Show / hide columns »

XML | RDF | TAB | « prev | Page of 5 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
HLA-DRAMajor histocompatibility complex, class II, DR alphaPlasma proteins
Predicted membrane proteins
Tissue enhanced
HLA-FMajor histocompatibility complex, class I, FPlasma proteins
Predicted membrane proteins
Tissue enhanced
HMHA1Histocompatibility (minor) HA-1Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
ICOSInducible T-cell co-stimulatorCD markers
Disease related genes
Predicted membrane proteins
Tissue enhanced
IFNGInterferon, gammaCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
IKZF1IKAROS family zinc finger 1 (Ikaros)Cancer-related genes
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Transcription factors
Nucleoplasm
Nucleoli
Vesicles		Tissue enhanced
IKZF3IKAROS family zinc finger 3 (Aiolos)Predicted intracellular proteins
Transcription factors
Plasma membrane
Cytosol		Tissue enhanced
IL12RB1Interleukin 12 receptor, beta 1CD markers
Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneTissue enhanced
IL16Interleukin 16Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Nuclear speckles
Plasma membrane
Cytosol		Tissue enhanced
IL17RELInterleukin 17 receptor E-likePredicted intracellular proteins
Tissue enhanced
IL21Interleukin 21Disease related genes
Plasma proteins
Predicted secreted proteins
Tissue enhanced
IL21RInterleukin 21 receptorCancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Plasma membrane
Cytosol		Tissue enhanced
IL2RAInterleukin 2 receptor, alphaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
IL2RGInterleukin 2 receptor, gammaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
VesiclesTissue enhanced
IRF4Interferon regulatory factor 4Cancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
NucleoplasmTissue enhanced
IRF8Interferon regulatory factor 8Disease related genes
Plasma proteins
Predicted intracellular proteins
Transcription factors
NucleoplasmTissue enhanced
ISG20Interferon stimulated exonuclease gene 20kDaEnzymes
Predicted intracellular proteins
NucleusTissue enhanced
ITGALIntegrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITKIL2-inducible T-cell kinaseCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Tissue enhanced
JAK3Janus kinase 3Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
CytosolTissue enhanced
KBTBD8Kelch repeat and BTB (POZ) domain containing 8Predicted intracellular proteins
Tissue enhanced
KIAA0101KIAA0101Predicted intracellular proteins
CentrosomeTissue enhanced
KIFC1Kinesin family member C1Plasma proteins
Predicted intracellular proteins
CentrosomeTissue enhanced
KLHL6Kelch-like family member 6Predicted intracellular proteins
Tissue enhanced
KLRK1Killer cell lectin-like receptor subfamily K, member 1Cancer-related genes
CD markers
Predicted membrane proteins
Plasma membraneTissue enhanced
LAIR1Leukocyte-associated immunoglobulin-like receptor 1CD markers
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneTissue enhanced
LAIR2Leukocyte-associated immunoglobulin-like receptor 2CD markers
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
LATLinker for activation of T cellsPlasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
LAT2Linker for activation of T cells family, member 2Disease related genes
Predicted secreted proteins
Tissue enhanced
LCKLCK proto-oncogene, Src family tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Golgi apparatusTissue enhanced
LEF1Lymphoid enhancer-binding factor 1Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Nuclear bodies
Cytosol		Tissue enhanced
LILRB1Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1Predicted membrane proteins
Tissue enhanced
LILRB4Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4CD markers
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
LMNB1Lamin B1Disease related genes
Plasma proteins
Predicted intracellular proteins
Nuclear membraneTissue enhanced
LRMPLymphoid-restricted membrane proteinPredicted intracellular proteins
Predicted membrane proteins
Nucleus
Vesicles
Cytosol		Tissue enhanced
LTALymphotoxin alphaCancer-related genes
Disease related genes
Predicted secreted proteins
Tissue enhanced
LY86Lymphocyte antigen 86Predicted secreted proteins
Tissue enhanced
LY9Lymphocyte antigen 9CD markers
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
MAP4K1Mitogen-activated protein kinase kinase kinase kinase 1Enzymes
Predicted intracellular proteins
Nucleoplasm
Plasma membrane		Tissue enhanced
MDS2Myelodysplastic syndrome 2 translocation associatedDisease related genes
Predicted intracellular proteins
Tissue enhanced
MICBMHC class I polypeptide-related sequence BDisease related genes
Predicted membrane proteins
Golgi apparatus
Vesicles		Tissue enhanced
MMP9Matrix metallopeptidase 9Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
CytosolTissue enhanced
MYBL1V-myb avian myeloblastosis viral oncogene homolog-like 1Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleus
Nucleoli
Cytosol		Tissue enhanced
MYBL2V-myb avian myeloblastosis viral oncogene homolog-like 2Cancer-related genes
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Cytosol		Tissue enhanced
MYO1GMyosin IGPredicted intracellular proteins
Tissue enhanced
NCF1Neutrophil cytosolic factor 1Disease related genes
Predicted intracellular proteins
Tissue enhanced
NCR3Natural cytotoxicity triggering receptor 3CD markers
Predicted membrane proteins
Tissue enhanced
NLRC3NLR family, CARD domain containing 3Plasma proteins
Predicted intracellular proteins
Microtubule organizing center
Cytosol		Tissue enhanced
NPHS1Nephrosis 1, congenital, Finnish type (nephrin)Disease related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
NUGGCNuclear GTPase, germinal center associatedPredicted intracellular proteins
Tissue enhanced

« prev | Page of 5 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.